What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Prostate cancer
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Surgery and Urology.
His biological study spans a wide range of topics, including Placebo and Pathology.
His research on Oncology also deals with topics like
- Androgen deprivation therapy that connect with fields like Disease,
- Targeted therapy most often made with reference to Sipuleucel-T.
His work deals with themes such as Abiraterone acetate, Adverse effect, Apalutamide and Hazard ratio, which intersect with Surgery.
His Apalutamide research is multidisciplinary, relying on both Darolutamide and Performance status.
His work focuses on many connections between Urology and other disciplines, such as Prednisone, that overlap with his field of interest in Docetaxel and Cancer biomarkers.
His most cited work include:
- Abiraterone and Increased Survival in Metastatic Prostate Cancer (3027 citations)
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy (2853 citations)
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy (1814 citations)
What are the main themes of his work throughout his whole career to date?
Fred Saad mainly investigates Prostate cancer, Internal medicine, Oncology, Urology and Surgery.
Cancer covers Fred Saad research in Prostate cancer.
His study focuses on the intersection of Internal medicine and fields such as Placebo with connections in the field of Clinical endpoint.
His Oncology research includes elements of Chemotherapy, Denosumab, Prednisone, Hazard ratio and Prostate-specific antigen.
Within one scientific family, Fred Saad focuses on topics pertaining to Epidemiology under Urology, and may sometimes address concerns connected to Cumulative incidence.
His studies in Zoledronic acid integrate themes in fields like Bone metastasis, Bisphosphonate and Bone disease.
He most often published in these fields:
- Prostate cancer (67.20%)
- Internal medicine (60.57%)
- Oncology (48.03%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (60.57%)
- Prostate cancer (67.20%)
- Oncology (48.03%)
In recent papers he was focusing on the following fields of study:
Fred Saad spends much of his time researching Internal medicine, Prostate cancer, Oncology, Urology and Epidemiology.
Fred Saad conducts interdisciplinary study in the fields of Prostate cancer and In patient through his works.
His work deals with themes such as Prostate-specific antigen, Clinical trial, Apalutamide and Radium-223, which intersect with Oncology.
His Urology research integrates issues from Renal cell carcinoma, Proportional hazards model, Nephrectomy and Lymph node.
His studies deal with areas such as Stage, Cancer, Marital status and Incidence as well as Epidemiology.
The concepts of his Androgen deprivation therapy study are interwoven with issues in Testosterone, Placebo and Clinical endpoint.
Between 2019 and 2021, his most popular works were:
- Olaparib for metastatic castration-resistant prostate cancer (222 citations)
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019[Formula presented] (88 citations)
- Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer (54 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His main research concerns Internal medicine, Prostate cancer, Oncology, Castration resistant and Enzalutamide.
His study in the field of Androgen deprivation therapy is also linked to topics like In patient.
Fred Saad has included themes like Prostate-specific antigen, Cancer, Adverse effect and MEDLINE in his Oncology study.
The various areas that Fred Saad examines in his Castration resistant study include Tumor response and Mutant.
His Enzalutamide research incorporates elements of Survival analysis, Abiraterone and Retrospective cohort study.
His Hazard ratio study combines topics from a wide range of disciplines, such as Prostatectomy, Radiation therapy, Proportional hazards model and Urology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
